Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/5f/b5/07/5fb5076e-ee87-2038-5971-0048ff35b0f8/mza_9409999970994965160.jpg/600x600bb.jpg

Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap.

Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC

322 episodes

5 days ago

Innovation isn't accidental; it's designed. Welcome to The Blueprint, a show committed to inventing the future and closing the gap between aspiration and achievement. We deconstruct the mechanics of success in modern science to provide access to the insights that matter most. Featuring masterclasses in leadership from icons such as Dr. Robert Langer, Chancellor Gary May, Provost Raheem Beyah, Dr. Todd Golub, and Greg Zuckerman, this is your guide to navigating—and leading—the next era of discovery.

Chemistry

Science

RSS

All content for Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap. is the property of Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/7605281/7605281-1763583382224-5bd54fa2cf71e.jpg

Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap.

1 hour 12 minutes 52 seconds

2 months ago

Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

Remixed- Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

---In this episode we provide and educational episode remix made with software assistance ( for educational purposes only) , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--

Please note: The views of this podcast represent those of my guest(s) and I, and do not constitute professional or medical advice or consultation. Please see a medical professional or healthcare professional for advice, suggestions and consultations. We disclaim any loss in any way.

Music citation: Open source